|
Index of reports
> Cases with Pneumonia (65)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neupogen (Filgrastim) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 65 Next >>
Possible Neupogen side effects in 46 year old male
Reported by a physician from Iran (Islamic Republic OF) on 2012-08-08
Patient: 46 year old male
Reactions: Pneumonia, Disseminated Tuberculosis, Meningitis Tuberculous
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Indication: Hairy Cell Leukaemia
Cladribine
Dosage: continous intravenous infusion over 7 days
Indication: Hairy Cell Leukaemia
Possible Neupogen side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-28
Patient: male, weighing 77.1 kg (169.6 pounds)
Reactions: Death, Pneumonia
Adverse event resulted in: death
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Carboplatin; Navelbine; Cetuximab; Taxol
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-05-08
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Febrile Neutropenia, Pyrexia, Muscle Rupture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Start date: 2011-04-26
Doxorubicin HCL
Start date: 2011-04-26
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Cyclophosphamide
Start date: 2011-04-26
Prednisone TAB
Administration route: Oral
Start date: 2011-04-26
Neupogen
Start date: 2011-06-29
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Doxorubicin HCL
Start date: 2011-06-28
Vincristine
Dosage: dosage form: unspecified
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Start date: 2011-06-28
Rituximab
Start date: 2011-06-28
Rituximab
Start date: 2011-05-03
Rituximab
Start date: 2011-04-26
Rituximab
Start date: 2011-07-02
End date: 2011-07-02
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-04
Cyclophosphamide
Dosage: dosage form: unspecified
Start date: 2011-06-28
Neupogen
Start date: 2011-04-27
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Prednisone TAB
Administration route: Oral
Start date: 2011-06-28
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Other drugs received by patient: Morphine Sulfate; Morphine; Acyclovir; Sennoside A+B; Lansoprazole; Furosemide; Enoxaparin Sodium; Amlodipine Besylate; Lactulose; Allopurinol; Sulfamethoxazole + Trimethoprim; Movicol / 01625101 /
Possible Neupogen side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25
Patient:
Reactions: Vomiting, Pneumonia, Nausea, Febrile Neutropenia, Rash, Hypokalaemia, Diarrhoea, Sepsis, Oedema, Decreased Appetite
Drug(s) suspected as cause:
Cladribine
Indication: Acute Myeloid Leukaemia Recurrent
Cytarabine
Indication: Acute Myeloid Leukaemia Recurrent
Neupogen
Indication: Acute Myeloid Leukaemia Recurrent
Imatinib Mesylate
Administration route: Oral
Indication: Acute Myeloid Leukaemia Recurrent
Possible Neupogen side effects in 64 year old male
Reported by a physician from Denmark on 2012-04-18
Patient: 64 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Febrile Neutropenia, Pyrexia, Muscle Rupture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2011-06-28
End date: 2011-07-02
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Cyclophosphamide
Dosage: 1500 mg, unk
Start date: 2011-06-28
Rituximab
Dosage: 750 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Neupogen
Dosage: 6 mg, unk
Start date: 2011-06-29
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Vincristine
Dosage: 2 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Vincristine
Dosage: 2 mg, unk
Start date: 2011-06-28
Rituximab
Dosage: 750 mg, unk
Start date: 2011-06-28
Prednisone
Dosage: 100 mg, qd
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
End date: 2011-04-30
Doxorubicin HCL
Dosage: 100 mg, unk
Start date: 2011-06-28
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-27
Rituximab
Dosage: 750 mg, unk
Start date: 2011-05-03
Other drugs received by patient: Morphine; Furosemide; Sennosides A+B; Allopurinol; Movicol-Half; Lansoprazole; Amlodipine; Acyclovir; Sulfametoxazol + Trimetoprima; Lactulose; Enoxaparin Sodium; Morphine Sulfate; Electrolytes NOS W / Macrogol 3350
Possible Neupogen side effects in 79 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-13
Patient: 79 year old female, weighing 76.0 kg (167.2 pounds)
Reactions: Pneumonia, Hypoglycaemia, Mental Status Changes, Hyponatraemia, Hypokalaemia, Diarrhoea, Sepsis, Colitis, Endocrine Disorder, Asthenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ipilimumab
Dosage: 1 df = 5mcg/ml,40ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-04
Neupogen
Dosage: d1-d14, 250mcg/ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-18
Other drugs received by patient: Valsartan; Metoprolol Tartrate; Zosyn; Potassium Chloride; Diphenhydramine HCL; Septra; Azithromycin; Ciprofloxacin; Pantoprazole; Insulin Lispro; Lisinopril; Januvia; Humalog; Vancomycin; Ceftriaxone; Lasix; Famotidine; Clonidine; Versed; Levemir; Mesalamine; Fentanyl; Albuterol; Ferrous Sulfate TAB
Possible Neupogen side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-14
Patient: 44 year old female
Reactions: Fluid Overload, Pneumonia, Vomiting, Nausea, International Normalised Ratio Increased, Pyrexia, Hypernatraemia, Mucosal Inflammation, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 341.5 mug, unk
Indication: Chemotherapy
Start date: 2011-10-09
End date: 2011-10-16
Melphalan Hydrochloride
Dosage: 169 mg, qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-10-01
End date: 2011-10-02
Possible Neupogen side effects in 64 year old male
Reported by a physician from United States on 2012-03-06
Patient: 64 year old male
Reactions: Pneumonia, Lung Infiltration, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Mozobil
Dosage: days 1-5
Indication: Myelodysplastic Syndrome
Start date: 2011-07-04
Azacitidine
Dosage: days 1-5
Indication: Myelodysplastic Syndrome
Start date: 2011-07-04
Possible Neupogen side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-28
Patient: 62 year old female, weighing 84.0 kg (184.8 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Rituximab
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-27
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Other drugs received by patient: Fluconazole; Sulfamethoxazole; Valaciclovir
Possible Neupogen side effects in 62 year old male
Reported by a physician from Denmark on 2012-02-23
Patient: 62 year old male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Cyclophosphamide
Dosage: 1800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Prednisolone
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Doxorubicin HCL
Dosage: 125 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Neupogen
Dosage: 6 mg, unk
Start date: 2011-09-04
Other drugs received by patient: Amoxicillin and Clavulanate Potassium; Ciprofloxacin; Sulfamethizole TAB
Possible Neupogen side effects in 64 year old male
Reported by a physician from Denmark on 2012-02-23
Patient: 64 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia, Febrile Neutropenia, Pulmonary Embolism, Pyrexia, Muscle Rupture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: dosage form: unspecified
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Rituximab
Dosage: dosage form: unspecified
Start date: 2011-07-02
End date: 2011-07-02
Rituximab
Dosage: dosage form: unspecified
Start date: 2011-04-26
Doxorubicin HCL
Dosage: dosage form: liposome injection
Start date: 2011-06-28
Doxorubicin HCL
Dosage: dosage form: liposome injection
Start date: 2011-04-26
Neupogen
Dosage: dosage form: unspecified
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-04
Neupogen
Dosage: dosage form: unspecified
Start date: 2011-06-29
Neupogen
Dosage: dosage form: unspecified
Start date: 2011-04-27
Vincristine Sulfate
Dosage: dosage form: unspecified
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Rituximab
Dosage: dosage form: unspecified
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Cyclophosphamide
Dosage: dosage form: unspecified
Start date: 2011-04-26
Vincristine Sulfate
Dosage: dosage form: unspecified
Start date: 2011-04-26
Doxorubicin HCL
Dosage: dosage form: liposome injection
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Cyclophosphamide
Dosage: dosage form: unspecified
Start date: 2011-06-28
Rituximab
Dosage: dosage form: unspecified
Start date: 2011-06-28
Prednisone TAB
Dosage: dosage form: unspecified
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Prednisone TAB
Administration route: Oral
Start date: 2011-04-26
Rituximab
Dosage: dosage form: unspecified
Start date: 2011-05-03
Prednisone TAB
Dosage: dosage form: unspecified
Administration route: Oral
Start date: 2011-06-28
Vincristine Sulfate
Dosage: dosage form: unspecified
Start date: 2011-06-28
Other drugs received by patient: Morphine Sulfate; Allopurinol; Amlodipine; Moviprep; Lansoprazole; Acyclovir; Lactulose; Sulfamethoxazole + Trimethoprim; Enoxaparin Sodium; Furosemide; Sennoside A+B; Morphine
Possible Neupogen side effects in 79 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-23
Patient: 79 year old female, weighing 76.0 kg (167.2 pounds)
Reactions: Pneumonia, Hypoglycaemia, Hyponatraemia, Hypokalaemia, Diarrhoea, Sepsis, Endocrine Disorder, Asthenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: d1-d14, 250mcg/ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-18
Ipilimumab
Dosage: 1 df = 5mcg/ml,40ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-04
Other drugs received by patient: Clonidine; Zosyn; Januvia; Ciprofloxacin; Metoprolol; Versed; Famotidine; Diphenhydramine HCL; Vancomycin; Ceftriaxone; Lisinopril; Valsartan; Humalog; Azithromycin; Fentanyl
Possible Neupogen side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-22
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Pneumonia, Diarrhoea, Gastric Ulcer, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-14
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Rituximab
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Cyclophosphamide
Dosage: 1400 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Doxorubicin HCL
Dosage: 93 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Other drugs received by patient: Sulfamethizole TAB
Possible Neupogen side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-22
Patient: 62 year old female, weighing 84.0 kg (184.8 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-27
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Rituximab
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Other drugs received by patient: Valaciclovir; Fluconazole; Sulfamethoxazole
Possible Neupogen side effects in 75 year old male
Reported by a physician from Denmark on 2012-02-20
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Pneumonia, Diarrhoea, Gastric Ulcer, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 93 mg, unk
Start date: 2011-04-11
Vincristine
Dosage: 2 mg, unk
Start date: 2011-04-11
Doxorubicin HCL
Dosage: 93 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Cyclophosphamide
Dosage: 1400 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Rituximab
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-14
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-11
Other drugs received by patient: Sulfamethoxazole
Possible Neupogen side effects in 64 year old male
Reported by a physician from Denmark on 2012-02-20
Patient: 64 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia, Febrile Neutropenia, Pulmonary Embolism, Pyrexia, Muscle Rupture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 100 mg, 1x/day
Start date: 2011-08-03
Prednisone
Dosage: 100 mg, qd
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Vincristine
Dosage: 2 mg, 1x/day
Start date: 2011-08-03
Rituximab
Dosage: 750 mg, 1x/day
Start date: 2011-07-02
Rituximab
Dosage: 750 mg, qd
Start date: 2011-08-03
Rituximab
Dosage: 750 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Rituximab
Dosage: 765 mg, qd
Start date: 2011-05-03
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Vincristine
Dosage: 2 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Prednisone
Dosage: 100 mg, 1x/day
Administration route: Oral
Start date: 2011-06-28
Vincristine
Dosage: 2 mg, 1x/day
Start date: 2011-06-28
Neupogen
Dosage: 6 mg, unk
Start date: 2011-08-04
Rituximab
Dosage: 750 mg, unk
Start date: 2011-06-28
Cyclophosphamide
Dosage: 1500 mg, 1x/day
Start date: 2011-08-03
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-27
Neupogen
Dosage: 6 mg, unk
Start date: 2011-06-29
Doxorubicin HCL
Dosage: 100 mg, 1x/day
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Doxorubicin HCL
Dosage: 100 mg, 1x/day
Start date: 2011-06-28
Prednisone
Dosage: 8800 mg, 1x/day
Start date: 2011-08-03
Cyclophosphamide
Dosage: 1500 mg, 1x/day
Start date: 2011-06-28
Other drugs received by patient: Lactulose; Morphine; Furosemide; Enoxaparin Sodium; Amlodipine; Sulfamethoxazole + Trimethoprim; Lansoprazole; Electrolytes NOS / Macrogol; Acyclovir; Allopurinol; Bran / FIG / Sennoside A+B; Morphine Sulfate; Moviprep
Possible Neupogen side effects in 62 year old male
Reported by a physician from Denmark on 2012-02-16
Patient: 62 year old male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 6 mg, unk
Start date: 2011-09-04
Prednisone
Dosage: 100 mg, unk
Start date: 2011-09-01
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Cyclophosphamide
Dosage: 1800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Rituximab
Dosage: 750 mg, unk
Start date: 2011-09-01
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Cyclophosphamide
Dosage: 1800 mg, unk
Start date: 2011-09-01
Doxorubicin HCL
Dosage: 125 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Doxorubicin HCL
Dosage: 120 mg, unk
Start date: 2011-09-01
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
End date: 2011-09-04
Vincristine Sulfate
Dosage: 2 mg, unk
Start date: 2011-09-01
Other drugs received by patient: Sulfamethoxazole; Ciprofloxacin; Amoxicillin and Clavulanate Potassium
Possible Neupogen side effects in female
Reported by a physician from Denmark on 2012-02-15
Patient: female, weighing 82.8 kg (182.2 pounds)
Reactions: Pneumonia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-12
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Fluconazole; Valacyclovir Hydrochloride
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-02-15
Patient: male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Cyclophosphamide
Start date: 2011-08-11
Neupogen
Start date: 2011-09-04
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
End date: 2011-09-01
Rituximab
Start date: 2011-08-11
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Prednisone TAB
Start date: 2011-09-01
Doxorubicin HCL
Start date: 2011-08-11
Other drugs received by patient: Sulfamethoxazole; Amoxicillin and Clavulanate Potassium; Ciprofloxacin
Possible Neupogen side effects in 79 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-12
Patient: 79 year old female, weighing 76.0 kg (167.2 pounds)
Reactions: Pneumonia, Hypoglycaemia, Hyponatraemia, Hypokalaemia, Diarrhoea, Sepsis, Endocrine Disorder, Asthenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ipilimumab
Dosage: 1 df = 5mcg/ml,40ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-04
Neupogen
Dosage: d1-d14, 250mcg/ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-18
Other drugs received by patient: Lisinopril; Famotidine; Metoclopramide; Ciprofloxacin; Azithromycin; Ceftriaxone; Diphenhydramine HCL; Versed; Humalog; Valsartan; Januvia; Zosyn; Vancomycin; Fentanyl Citrate; Clonidine
Possible Neupogen side effects in 79 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-31
Patient: 79 year old female, weighing 76.0 kg (167.2 pounds)
Reactions: Atelectasis, Pneumonia, Hypoglycaemia, Hyponatraemia, Blood Thyroid Stimulating Hormone Decreased, Hypokalaemia, Diarrhoea, Oedema Peripheral, Endocrine Disorder, Asthenia, White Blood Cell Count Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: d1-d14, 250mcg/ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-18
Ipilimumab
Dosage: 1 df = 5mcg/ml,40ml vials
Indication: Malignant Melanoma
Start date: 2011-10-20
End date: 2012-01-04
Other drugs received by patient: Clonidine; Famotidine; Januvia; Valsartan; Diphenhydramine HCL; Lisinopril; Metoprolol Tartrate
Possible Neupogen side effects in 62 year old male
Reported by a physician from Denmark on 2012-01-23
Patient: 62 year old male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 2 mg, unk
Start date: 2011-09-01
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Cyclophosphamide
Dosage: 1800 mg, unk
Start date: 2011-09-01
Cyclophosphamide
Dosage: 1800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Rituximab
Dosage: 750 mg, unk
Start date: 2011-09-01
Doxorubicin HCL
Dosage: 125 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Doxorubicin HCL
Dosage: 120 mg, unk
Start date: 2011-09-01
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Neupogen
Dosage: 6 mg, unk
Start date: 2011-09-04
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Prednisone TAB
Dosage: 100 mg, unk
Start date: 2011-09-01
Other drugs received by patient: Ciprofloxacin; Sulfamethoxazole; Amoxicillin and Clavulanate Potassium
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-01-16
Patient: male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Vincristine
Start date: 2011-08-11
Cyclophosphamide
Start date: 2011-08-11
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Prednisone
Start date: 2011-09-01
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Doxorubicin HCL
Start date: 2011-08-11
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Neupogen
Start date: 2011-09-04
Rituximab
Start date: 2011-08-11
Other drugs received by patient: Ciprofloxacin; Sulfamethoxazole; Amoxicillin and Clavulanate Potassium
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-01-16
Patient: male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-09-01
Neupogen
Start date: 2011-09-04
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Prednisone
Start date: 2011-09-01
Vincristine
Start date: 2011-08-11
Doxorubicin HCL
Start date: 2011-08-11
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Other drugs received by patient: Ciprofloxacin; Amoxicillin and Clavulanate Potassium; Sulfamethoxazole
Possible Neupogen side effects in 62 year old male
Reported by a physician from Denmark on 2012-01-13
Patient: 62 year old male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Cyclophosphamide
Dosage: 1800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Rituximab
Dosage: 750 mg, unk
Start date: 2011-09-01
Prednisone
Dosage: 100 mg, unk
Start date: 2011-09-01
Doxorubicin HCL
Dosage: 120 mg, unk
Start date: 2011-09-01
Neupogen
Dosage: 6 mg, unk
Start date: 2011-09-04
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Cyclophosphamide
Dosage: 1800 mg, unk
Start date: 2011-09-01
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Vincristine Sulfate
Dosage: 2 mg, unk
Start date: 2011-09-01
Doxorubicin HCL
Dosage: 125 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Other drugs received by patient: Sulfamethoxazole; Ciprofloxacin; Amoxicillin and Clavulanate Potassium
Possible Neupogen side effects in female
Reported by a physician from Denmark on 2012-01-12
Patient: female, weighing 82.8 kg (182.2 pounds)
Reactions: Pneumonia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-26
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-12
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Fluconazole; Valacyclovir Hydrochloride
Possible Neupogen side effects in 70 year old female
Reported by a physician from Netherlands on 2012-01-10
Patient: 70 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-02-26
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-02-27
Rituximab
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-02-26
Cyclophosphamide
Dosage: 1400 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-02-26
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-02-26
Doxorubicin HCL
Dosage: 94 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-02-26
Possible Neupogen side effects in 64 year old male
Reported by a physician from Denmark on 2012-01-10
Patient: 64 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Febrile Neutropenia, Pyrexia, Muscle Rupture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 765 mg, qd
Start date: 2011-05-03
Rituximab
Dosage: 750 mg, qd
Start date: 2011-08-03
Prednisone TAB
Dosage: 8800 mg, 1x/day
Start date: 2011-08-03
Doxorubicin HCL
Dosage: unk
Start date: 2011-06-28
Neupogen
Dosage: unk mg, 1x/day
Start date: 2011-08-04
Rituximab
Dosage: 750 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Vincristine
Dosage: 2 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Doxorubicin HCL
Dosage: 100 mg, 1x/day
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-27
Prednisone TAB
Dosage: 100 mg, 1x/day
Start date: 2011-06-28
Neupogen
Dosage: unk
Start date: 2011-06-29
Prednisone TAB
Dosage: 100 mg, qd
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Lactulose; Moviprep; Amlodipine; Allopurinol; Morphine; Acyclovir; Lansoprazole; Enoxaparin Sodium; Furosemide; Sennoside A+B; Morphine Sulfate
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-01-09
Patient: male, weighing 109.0 kg (239.8 pounds)
Reactions: Pneumonia, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-09-01
Neupogen
Start date: 2011-09-04
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Doxorubicin HCL
Start date: 2011-08-11
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-15
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Prednisone TAB
Start date: 2011-09-01
Vincristine
Start date: 2011-08-11
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-11
Other drugs received by patient: Amoxicillin and Clavulanate Potassium; Sulfamethoxazole; Ciprofloxacin
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-01-03
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Blood Phosphorus Increased, Febrile Neutropenia, Pulmonary Embolism, Pyrexia, Muscle Rupture, Haemoglobin Decreased, International Normalised Ratio Decreased, Pleural Effusion, Blood Creatinine Increased, Coagulation Time Prolonged
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Prednisone TAB
Administration route: Oral
Start date: 2011-06-28
Vincristine
Start date: 2011-06-28
Rituximab
Start date: 2011-04-26
Doxorubicin HCL
Start date: 2011-06-28
Doxorubicin HCL
Start date: 2011-08-03
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-04
Rituximab
Start date: 2011-08-03
Vincristine
Start date: 2011-04-26
Cyclophosphamide
Start date: 2011-06-28
Cyclophosphamide
Start date: 2011-08-03
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-04-26
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-07-02
Neupogen
Start date: 2011-04-27
Neupogen
Start date: 2011-06-29
Prednisone TAB
Administration route: Oral
Start date: 2011-08-03
Rituximab
Start date: 2011-05-03
Rituximab
Start date: 2011-06-28
Other drugs received by patient: Acyclovir; Amlodipine; Morphine; Sennoside; Lactulose; Moviprep; Furosemide; Lansoprazole; Morphine Sulfate; Allopurinol; Enoxaparin Sodium; Sulfamethoxazol and Trimethoprim
Page 1 Next >>
|
